Dr James Curran, mostly known for his work at the Centers for Disease Control and Prevention (CDC) in the 1980's, pinpoints several key events and persons linked with the very first years of discoveries on HIV and AIDS.

A short history of HIV and AIDS in Sweden, based on clips from the FoA archive.

This is the story about Steve Sjöquist - writer, HIV activist and deacon at Karolinska Universitetssjukhuset in Stockholm. Steve was diagnosed with HIV in 1987 and he was one of the first Swedish AIDS patients to get the new antiretroviral therapy in 1996. It saved his life.

Staffan Hildebrand returns to Australia, where he started his project of documenting the AIDS epidemic in 1988, and to Cambodia where he first arrived in 1998. He interviews some of the scientists and activists who he met back then and displays some footage from the archive.

Interview with David Cooper, Director of The Kirby Institute at the University of New South Wales.

This is a pre-version of the documentary about the writer and AIDS activist, Steve Sjöquist, who was diagnosed with HIV in 1987. Steve was one of the first Swedish AIDS patients to get the new ARV medication in 1996, and it saved his life.

XIX International AIDS Conference. Interview with Adeeba Kamarulzaman from the University of Malaya in Kuala Lumpur, Malaysia. She talks about the obstacles and possibilities of ending HIV and AIDS.

XIX International AIDS Conference in Washington D.C. Gottfried Hirnshall is Director of Department of HIV and Global Hepatitis Programme at the WHO. Here he talks about what needs to be done from a health policy perspective to end AIDS, and the role of WHO.

XIX International AIDS Conference. The co-chair of this conference, Diane Havlir, has been working with HIV/AIDS since the early 80's at San Francisco General Hospital. Here she talks about the time of the outbreak and about the tools needed to end HIV and AIDS.

XIX International AIDS Conference in Washington D.C. Interview with MD Judith Currier from the UCLA Center for AIDS Research (CFAR) on ending AIDS. She also talks about aspects of aging and living with HIV which is one of her focuses in research.

XIX International AIDS Conference. Interview with Gregg Alton from the Gilead Sciences, Inc. a pharmaceutical company working with health care services, policy makers, etc. to develop effective treatment, treatment as prevention and promoting access to care.

XIX International AIDS Conference. Matias Ostrowski from University of Buenos Aires is part of the CNIHR program lead by IAS and NIH. He is involved in basic research on the cell biology of HIV with the target of creating new ideas for drug development.